2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

Sean Martin Biography and Net Worth

SVP of Baxter International

Sean Martin is senior vice president and general counsel.

Martin joined Baxter in 2017 from Apollo Education Group, Inc., where he served as senior vice president, general counsel and secretary from 2010 to 2017. Previously, he served as assistant secretary (2010), vice president of corporate law (2009 to 2010) and vice president of commercial law (2005 to 2009) for Amgen Inc. He also served as vice president and deputy general counsel at Fresenius Medical Care North America from 2000 to 2005. Martin was a partner at the law firm Foley & Lardner LLP from 1998 to 2000 and served eight years as Assistant U.S. Attorney for the Northern District of Illinois.

He serves as executive sponsor of Early Career Professionals, a business resource group focused on helping early career professionals at Baxter achieve their professional development aspirations and maximize their contributions to Baxter’s business objectives.

Martin received a bachelor of arts in history from the University of Michigan and a Juris Doctorate from Harvard Law School.

What is Sean Martin's net worth?: The estimated net worth of Sean Martin is at least $1.17 million as of March 30th, 2020. Mr. Martin owns 39,504 shares of Baxter International stock worth more than $1,165,368 as of December 22nd. This net worth evaluation does not reflect any other assets that Mr. Martin may own. Learn More about Sean Martin's net worth.
How do I contact Sean Martin?: The corporate mailing address for Mr. Martin and other Baxter International executives is One Baxter Parkway DF2-1W, Deerfield IL, 60015. Baxter International can also be reached via phone at (224) 948-2000 and via email at [email protected]. Learn More on Sean Martin's contact information.
Has Sean Martin been buying or selling shares of Baxter International?: Sean Martin has not been actively trading shares of Baxter International during the last quarter. Most recently, on Monday, March 30th, Sean Martin bought 9,780 shares of Baxter International stock. The stock was acquired at an average cost of $82.19 per share, with a total value of $803,818.20. Following the completion of the transaction, the senior vice president now directly owns 39,504 shares of the company's stock, valued at $3,246,833.76. Learn More on Sean Martin's trading history.
Who are Baxter International's active insiders?: Baxter International's insider roster includes Giuseppe Accogli (SVP), John Forsyth (Director), Andrew Frye (SVP), James Gavin, III (Director), Jacqueline Kunzler (SVP), Sean Martin (SVP), Jeanne Mason (SVP), Brian Stevens (CAO), and Albert Stroucken (Director). Learn More on Baxter International's active insiders.

Sean Martin Insider Trading History at Baxter International

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/30/2020	Buy	9,780	$82.19	$803,818.20	39,504

Sean Martin Buying and Selling Activity at Baxter International

Baxter International Company Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Today's Range

Now: $29.50

$29.17

$29.99

50 Day Range

MA: $33.70

$28.90

$36.91

2 Week Range

Now: $29.50

$28.62

$44.01

Volume

12,194,859 shs

Average Volume

4,174,975 shs

Market Capitalization

$15.06 billion

P/E Ratio

147.51

Dividend Yield

2.35%

Beta

0.58

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now